Date	Period	Revenue/Estimate	Earnings Call
--	2027/Q1	-- / 22.500B	--
--	2026/Q1	-- / 21.500B	--
Jul 30, 2024	2025/Q1	21.164B / 19.800B	--
Jan 30, 2024	2024/Q3	20.881B / --	--
Jul 31, 2023	2024/Q1	19.313B / 17.750B	--

DatePeriodRevenue/EstimateEarnings Call

--2027/Q1-- / 22.500B--

--2026/Q1-- / 21.500B--

Jul 30, 20242025/Q121.164B / 19.800B--

Jan 30, 20242024/Q320.881B / ----

Jul 31, 20232024/Q119.313B / 17.750B--

Unlock Free Earnings Estimates

Open Account

Kissei Pharmaceutical Earnings Reports

Kissei Pharmaceutical: Confirmation letter

Nov 12 23:01 ET

Kissei Pharmaceutical: Half Year Report - Term 80 (2024/04/01 - 2025/03/31)

Nov 12 23:00 ET

Kissei Pharmaceutical: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3

Nov 6 02:00 ET

Kissei Pharmaceutical: Consolidated Financial Results for the 2nd Quarter (Interim Period) for the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 5 02:30 ET

Analyst Rating

Updated: Dec 27, 2024

Hold

Strong Buy
0.00%
Buy
33.33%
Hold
66.67%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data

4547 Kissei Pharmaceutical

Kissei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kissei Pharmaceutical Q2 2025 Earnings Date

Kissei Pharmaceutical Earnings Estimates

Kissei Pharmaceutical Earnings Reports

Analysis

Analyst Rating

Price Target